https://admin1.seo.com.cn/CustomerAdmin/S_News/Create?ru=%2FCustomerAdmin%2FS_News%2F%3Fpage%3D2

The global market for PTC needles (Chiba Needle / PTC Access Needle) is steadily expanding alongside the growth of minimally invasive interventional procedures. According to industry data, the global market for PTC needles and related biliary interventional puncture needles was valued at approximately USD 1.13 billion in 2026 and is projected to reach USD 1.92 billion by 2033, with a CAGR of about 7.4%. Driving factors include: aging populations leading to increased incidence of hepatobiliary/pancreatic tumors and gallstones; rising demand for minimally invasive drainage of obstructive jaundice; PTC/PTCD becoming an important alternative when ERCP fails or anatomical variations exist; and the proliferation of ultrasound guidance equipment making fine-needle PTC easier to perform.

Competitive Landscape:​ The high-end market has long been dominated by Cook Medical (USA), BD/Argon (USA), TSK/Hakko/Hakkou (Japan), known for product reliability and strong clinical recognition. Domestic manufacturers in China and other emerging markets (such as Jingfang Medical, Kindly, and other companies involved in interventional product lines) are rapidly catching up with ISO 13485-certified production lines, cost advantages, and customized services, expanding their share in mid-tier hospitals and primary care markets. Domestic tertiary hospitals are gradually accepting high-end domestic models (with ultrasound visibility markers, Nitinol shafts, hydrophilic coatings), and the trend of domestic substitution is clear.

Product Differentiation Directions:

• Ultrasound-Enhanced Chiba Needles:Tip micro-pitting / spiral etching + high-brightness echo, catering to the trend of widespread ultrasound guidance.
• PTC Starter Kits:22G Chiba needle + 0.018″ hydrophilic guidewire + positioning pad + sterile drape, enhancing procedural convenience.
• Material Upgrades:NiTi shafts resist kinking for multi-adjustment scenarios; 316L medical stainless steel promotes superior corrosion resistance.
• OEM/ODM Customization:Custom lengths (12–30 cm), gauges (18G–23G), hub types, multilingual labels, and individual blister packaging per overseas client drawings, facilitating exports.

Environmental and Compliance:Strict EO residue control, latex-free, pyrogen-free declarations to meet European and American procurement standards.

Challenges and Opportunities:​ Alternative diagnostic methods (MRCP, EUS) divert some PTC volume in non-obstructive cases, but malignant obstructions, hilar strictures, and post-gastrointestinal-bypass patients who are unsuitable for ERCP remain strongly reliant on PTC/PTCD-the fundamental demand is solid. A shortage of skilled interventional radiologists is a bottleneck in some regions; manufacturers can cultivate users by co-hosting "PTC Fine-Needle Puncture Workshops" with medical societies. Under domestic centralized procurement policies, local PTC needle manufacturers with comprehensive quality systems, clinical evidence (puncture success/complication data), and after-sales training will gain greater advantages in public hospital tenders.

Looking ahead, as a high-frequency, low-to-medium-value interventional consumable, the manufacturing threshold for PTC needles does not lie in "being able to make them," but in "consistently producing excellent sharpness, smoothness, and visibility in every batch." For manufacturers, deepening process expertise, improving kit配套, and proactively participating in clinical education and training are the keys to establishing lasting competitiveness in the global PTC needle niche market.